MDM medical monitors limited

market cap still small, page-5

  1. 34,500 Posts.
    lightbulb Created with Sketch. 1
    re: summary looks promising NOTES: TO MARCH 31, 2003

    The Company is pleased to announce that it has consolidated a number
    of sales opportunities for Medical Monitors' technology and services,
    with top tier international pharmaceutical companies in Australia and
    overseas. In particular, first phase sales have been completed with
    Australian subsidiaries of these companies, providing an initial
    $253,000 of sales revenue.

    The Company expects to be in a 'cash positive' position over the
    coming months, with progressive sales revenue of more than $1 million
    anticipated from these entities in Australia alone.

    A review of the quarterly activities includes:

    * Medical Monitors' wholly owned USA subsidiary, Wellness Monitoring,
    is in final discussions for a service contract with a US-based
    pharmaceutical company to provide BPfone(TM) units for a planned
    blood pressure drug evaluation trial. As previously stated, multi
    level 'drug evaluation trials' will provide significant sales
    opportunity for the BPfone(TM), with more than US$2 million expected
    from this initial contract.

    * Care Medic al Limited, the UK joint venture (JV) company for
    Medical Monitors, continues to provide the BPfone(TM) blood pressure
    monitoring system for the medical and pharmacy community. It is
    currently in final evaluation trials, with a leading pharmacy chain,
    for this program to expand UK-wide. It is anticipated that future
    sales contracts will attract more than 1 million pounds of revenue
    from these activities.

    * Bosch + Sohn has finalised the next phase of manufacture of
    BPfone(TM) blood pressure units in preparation for the fulfilment of
    sales contracts currently under negotiation. As previously stated,
    Bosch + Sohn has specialised in quality blood pressure
    instrumentation, over the past 35 years, and is the leading blood
    pressure monitoring product distributor in Europe. Bosch + Sohn.

    * The HMS Monitoring Service, the Malaysian provider for the
    BPfone(TM) monitoring service, has undertaken an evaluation trial
    with the Gleneagles group - a premier private health care
    institution. Final discussions are also in progress with one of the
    top tier pharmaceutical companies to provide the BPfone(TM) in a
    Malaysia -wide health promotion program. Sales revenues are expected
    over the coming quarter.

    * In February, 2003, the Company received an initial payment of
    $60,000, from Austrade's EMDG program (Export Market Development
    Grant) and is flagged to receive a further payment of up to $140,000
    over this next quarter. This program provides assistance with
    marketing and promotional expenses for Australian companies
    developing export markets.

    * The Company has recently initiated the $660,000 'line of credit',
    provided through Provident Capital. This will allow for more
    efficient use of working capital and will provide the Company with
    the necessary funding to build its inventory base.

    As previously stated, the combination of monies raised in the
    previous quarter, and the anticipated sales revenue over the coming
    months, provide a sound financial base for the Company to continue
    with its current sales and marketing programs in Australia and
    overseas.
 
watchlist Created with Sketch. Add MDM (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.